There are a number of potential interactions between cannabis and other substances. The Monitoring the Future study, for example, aims to measure the use and perceived risks of cannabis among high school students. It has also been linked to the negative effects of alcohol, cocaine, and anticholinergic agents. While few case reports have been published, there is some evidence to suggest that cannabis may interact with a variety of other drugs, including alcohol, cocaine, and St. John’s wort.
As the potency of cannabis varies greatly, it can be difficult to predict how much a person will tolerate. Considering the limited scientific evidence to date, patients should seek a physician’s advice before trying cannabis for medical purposes. In a 2017 study, for example, patients who were suffering from depression reported less stress after using cannabis, but those who were coping with PTSD showed a higher level of anxiety. A small amount of cannabis may help ease the effects of chronic tension but should be taken with caution.
Recent studies indicate that cannabis may have therapeutic benefits in neuropathic pain and chemotherapy-induced nausea. However, the drug has a long way to go until legalization in the U.S. It may be used in concomitant therapy with other treatments. In the meantime, the availability of cannabis products in the U.S. will limit its use. The lack of research has led to several issues, including bias, unintended side effects, and methodological limitations.
Researchers are developing a new tool to assess the latest research on marijuana. STEM is a web-based tool that researchers and clinicians can use to evaluate the latest evidence on cannabis. The STEM website includes a series of clinical briefs and a visual abstract summary of the findings. Cannabis is legal in Australia, and many studies have been conducted since it was first introduced. Its advantages include:
In the past decade, cannabis and cannabinoids have been studied for various medical conditions. While no medical trials have been conducted to prove the efficacy of cannabis, it has been suggested for certain conditions. Despite these concerns, the federal government has passed legislation that allows cannabis-based medicines to be grown in Australia for medical use. While the federal government has banned government-funded research on cannabis and cannabinoids, these studies are still a good indicator of potential benefits.
The medical community must develop tools to diagnose problem cannabis use and provide the means to treat it. Moreover, it should deliver evidence-based messages to the public regarding marijuana use, including the risks and benefits of cannabis. By educating the public, we can prevent the development of public health issues related to cannabis. The National Epidemiologic Survey on Alcohol Related Conditions is one way to promote the development of prevention and harm reduction. With this, the medical community can help prevent a number of health problems related to cannabis use.
CBD-rich products are becoming immensely popular around the world. Initially, it was developed as a self-medication for children suffering from Dravet syndrome. Since then, it has been used to treat a wide range of ailments. Today, cannabidiol is available in a variety of dosage forms. The most popular form of cannabidiol, CBD oil, is produced by hundreds of companies, from home-grown hemp to pharmaceutical firms.